Table 1. Baseline Characteristics of the Study Population.
| variables | CAD patients (n = 174) | controls (n = 36) | F value/chi-square | P value |
|---|---|---|---|---|
| gender (M/F) | 130/44 | 18/18 | 8.775 | 0.003 |
| age (years) | 63.71 ± 11.28 | 63.61 ± 10.52 | –0.043 | 0.966 |
| BMI (kg/m2) | 24.98 ± 3.05 | 25.06 ± 2.64 | 0.142 | 0.887 |
| smoking, n (%) | 43.7 | 33.3 | 1.123 | 0.289 |
| drinking, n (%) | 27.6 | 20.0 | 0.757 | 0.384 |
| hypertension, n (%) | 62.1 | 50.0 | 1.557 | 0.212 |
| SBP (mmHg) | 129.80 ± 16.90 | 133.47 ± 19.10 | 1.075 | 0.284 |
| DBP (mmHg) | 76.17 ± 11.92 | 80.63 ± 9.54 | 1.946 | 0.053 |
| CRP (mg/L) | 3.19 (1.56–4.71) | 2.12 (1.53–5.03) | –0.748 | 0.455 |
| total cholesterol (mg/dL) | 3.62 (3.06–4.32) | 3.81 (3.00–4.67) | –0.457 | 0.658 |
| TG (mg/dL) | 1.30 (0.95–1.72) | 1.28 (0.88–1.67) | –0.325 | 0.745 |
| HDL-C (mg/dL) | 0.97 (0.85–1.15) | 1.04 (0.85–1.26) | –1.110 | 0.267 |
| LDL-C (mg/dL) | 2.08 (1.67–2.65) | 2.17 (1.73–2.82) | –0.511 | 0.609 |
| GLU (mg/dL) | 5.23 (4.62–6.20) | 5.07 (4.58–5.82) | –0.814 | 0.416 |
| Lp (a) (mg/L) | 172.00 (72.00–387.00) | 122.50 (69.50–235.50) | –1.254 | 0.210 |
| Gensini score | 62.00 (25.50–100.00) | 0.00 (0.00–4.75) | –9.169 | P < 0.001 |